Cover Image
Market Research Report
Product code 
1097707

Pneumonia Testing Market By Types, By Method, By Technology, By End User : Global Opportunity Analysis and Industry Forecast, 2020-2030

Published: | Allied Market Research | 180 Pages | Delivery time: 2-3 business days

Price

Back to Top
Pneumonia Testing Market By Types, By Method, By Technology, By End User : Global Opportunity Analysis and Industry Forecast, 2020-2030
Published: April 1, 2022
Allied Market Research
Content info: 180 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Pneumonia is indicated as a complex infection, which affects the lower part of the respiratory tract along with the deposition of cough in the lungs. It may even occur as a consequence of an upper tract infection. Frequently, it occurs in people with weakened immunity, the geriatric population, and children. Biotechnological methods can be used for testing of pneumonia, such as enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR).

The major driving factors contributing to the growth of the pneumonia market are an increase in awareness regarding early diagnosis, a rise in the popularity of point of care (POC)testing, and surge in government expenditures on healthcare. However, limited detection capability, the accuracy of some of the pneumonia testing products, and regulatory & economic hurdles hamper the market growth. Some of the factors, such as an increase in the adoption of molecular diagnostic testing and untapped markets in developing countries are expected to provide lucrative growth opportunities for the pneumonia testing market.

The pneumonia testing market is segmented on the basis of, and region. Method, technology, type & end user. In terms of method, the market is classified into immunodiagnostics, molecular diagnostics, and point-of-care (POC) testing. By type, it is bifurcated into analyzers and consumables. Based on technology, it is categorized into enzyme-linked immunosorbent assay (ELISA), immunofluorescence, western blot, polymerase chain reaction (PCR), immunohistochemistry (IHC), and others. Depending on the end-user, it is categorized into hospitals, diagnostic laboratories, home care, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the market include Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux, Becton, Dickenson and Company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, and Quidel.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pneumonia testing market analysis from 2020 to 2030 to identify the prevailing pneumonia testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pneumonia testing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pneumonia testing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Types

  • Consumables
  • Analyzers

By Method

  • Molecular Diagnostics
  • Point of Care Testing
  • Immunodiagnostics

By Technology

  • Enzyme Linked Immunosorbant Assay
  • Immunofluoroscence
  • Western Blot
  • Polymerase Chain Reaction
  • Imunohistochemistry
  • Others

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Homecare
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest Of Asia Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Abott Laboratories
    • F.hoffman La roche
    • Thermofischer Inc
    • Hologic Inc
    • Biomerieux SA
    • Quidel Corporation
    • Bio Rad laborateries
    • Beckton and Dickinson Company
    • AdvanDx
    • Beckman Coulter
Product Code: A03434

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: PNEUMONIA TESTING MARKET, BY TYPES

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Consumables
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Analyzers
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: PNEUMONIA TESTING MARKET, BY METHOD

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Immunodiagnostics
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Molecular Diagnostics
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Point of Care Testing
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: PNEUMONIA TESTING MARKET, BY TECHNOLOGY

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Enzyme Linked Immunosorbent Assay
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Immunofluorescence
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Western Blot
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country
  • 6.5 Polymerase Chain Reaction
    • 6.5.1 Key market trends, growth factors and opportunities
    • 6.5.2 Market size and forecast, by region
    • 6.5.3 Market analysis by country
  • 6.6 Immunohistochemistry
    • 6.6.1 Key market trends, growth factors and opportunities
    • 6.6.2 Market size and forecast, by region
    • 6.6.3 Market analysis by country
  • 6.7 Others
    • 6.7.1 Key market trends, growth factors and opportunities
    • 6.7.2 Market size and forecast, by region
    • 6.7.3 Market analysis by country

CHAPTER 7: PNEUMONIA TESTING MARKET, BY END USER

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 Hospitals
    • 7.2.1 Key market trends, growth factors and opportunities
    • 7.2.2 Market size and forecast, by region
    • 7.2.3 Market analysis by country
  • 7.3 Diagnostic Laboratories
    • 7.3.1 Key market trends, growth factors and opportunities
    • 7.3.2 Market size and forecast, by region
    • 7.3.3 Market analysis by country
  • 7.4 Homecare
    • 7.4.1 Key market trends, growth factors and opportunities
    • 7.4.2 Market size and forecast, by region
    • 7.4.3 Market analysis by country
  • 7.5 Others
    • 7.5.1 Key market trends, growth factors and opportunities
    • 7.5.2 Market size and forecast, by region
    • 7.5.3 Market analysis by country

CHAPTER 8: PNEUMONIA TESTING MARKET, BY REGION

  • 8.1 Overview
    • 8.1.1 Market size and forecast
  • 8.2 North America
    • 8.2.1 Key trends and opportunities
    • 8.2.2 North America Market size and forecast, by Types
    • 8.2.3 North America Market size and forecast, by Method
    • 8.2.4 North America Market size and forecast, by Technology
    • 8.2.5 North America Market size and forecast, by End User
    • 8.2.6 North America Market size and forecast, by country
      • 8.2.6.1 U.S.
      • 8.2.6.1.1 Market size and forecast, by Types
      • 8.2.6.1.2 Market size and forecast, by Method
      • 8.2.6.1.3 Market size and forecast, by Technology
      • 8.2.6.1.4 Market size and forecast, by End User
      • 8.2.6.2 Canada
      • 8.2.6.2.1 Market size and forecast, by Types
      • 8.2.6.2.2 Market size and forecast, by Method
      • 8.2.6.2.3 Market size and forecast, by Technology
      • 8.2.6.2.4 Market size and forecast, by End User
      • 8.2.6.3 Mexico
      • 8.2.6.3.1 Market size and forecast, by Types
      • 8.2.6.3.2 Market size and forecast, by Method
      • 8.2.6.3.3 Market size and forecast, by Technology
      • 8.2.6.3.4 Market size and forecast, by End User
  • 8.3 Europe
    • 8.3.1 Key trends and opportunities
    • 8.3.2 Europe Market size and forecast, by Types
    • 8.3.3 Europe Market size and forecast, by Method
    • 8.3.4 Europe Market size and forecast, by Technology
    • 8.3.5 Europe Market size and forecast, by End User
    • 8.3.6 Europe Market size and forecast, by country
      • 8.3.6.1 Germany
      • 8.3.6.1.1 Market size and forecast, by Types
      • 8.3.6.1.2 Market size and forecast, by Method
      • 8.3.6.1.3 Market size and forecast, by Technology
      • 8.3.6.1.4 Market size and forecast, by End User
      • 8.3.6.2 France
      • 8.3.6.2.1 Market size and forecast, by Types
      • 8.3.6.2.2 Market size and forecast, by Method
      • 8.3.6.2.3 Market size and forecast, by Technology
      • 8.3.6.2.4 Market size and forecast, by End User
      • 8.3.6.3 U.K.
      • 8.3.6.3.1 Market size and forecast, by Types
      • 8.3.6.3.2 Market size and forecast, by Method
      • 8.3.6.3.3 Market size and forecast, by Technology
      • 8.3.6.3.4 Market size and forecast, by End User
      • 8.3.6.4 Italy
      • 8.3.6.4.1 Market size and forecast, by Types
      • 8.3.6.4.2 Market size and forecast, by Method
      • 8.3.6.4.3 Market size and forecast, by Technology
      • 8.3.6.4.4 Market size and forecast, by End User
      • 8.3.6.5 Spain
      • 8.3.6.5.1 Market size and forecast, by Types
      • 8.3.6.5.2 Market size and forecast, by Method
      • 8.3.6.5.3 Market size and forecast, by Technology
      • 8.3.6.5.4 Market size and forecast, by End User
      • 8.3.6.6 Rest of Europe
      • 8.3.6.6.1 Market size and forecast, by Types
      • 8.3.6.6.2 Market size and forecast, by Method
      • 8.3.6.6.3 Market size and forecast, by Technology
      • 8.3.6.6.4 Market size and forecast, by End User
  • 8.4 Asia-Pacific
    • 8.4.1 Key trends and opportunities
    • 8.4.2 Asia-Pacific Market size and forecast, by Types
    • 8.4.3 Asia-Pacific Market size and forecast, by Method
    • 8.4.4 Asia-Pacific Market size and forecast, by Technology
    • 8.4.5 Asia-Pacific Market size and forecast, by End User
    • 8.4.6 Asia-Pacific Market size and forecast, by country
      • 8.4.6.1 Japan
      • 8.4.6.1.1 Market size and forecast, by Types
      • 8.4.6.1.2 Market size and forecast, by Method
      • 8.4.6.1.3 Market size and forecast, by Technology
      • 8.4.6.1.4 Market size and forecast, by End User
      • 8.4.6.2 China
      • 8.4.6.2.1 Market size and forecast, by Types
      • 8.4.6.2.2 Market size and forecast, by Method
      • 8.4.6.2.3 Market size and forecast, by Technology
      • 8.4.6.2.4 Market size and forecast, by End User
      • 8.4.6.3 Australia
      • 8.4.6.3.1 Market size and forecast, by Types
      • 8.4.6.3.2 Market size and forecast, by Method
      • 8.4.6.3.3 Market size and forecast, by Technology
      • 8.4.6.3.4 Market size and forecast, by End User
      • 8.4.6.4 India
      • 8.4.6.4.1 Market size and forecast, by Types
      • 8.4.6.4.2 Market size and forecast, by Method
      • 8.4.6.4.3 Market size and forecast, by Technology
      • 8.4.6.4.4 Market size and forecast, by End User
      • 8.4.6.5 South Korea
      • 8.4.6.5.1 Market size and forecast, by Types
      • 8.4.6.5.2 Market size and forecast, by Method
      • 8.4.6.5.3 Market size and forecast, by Technology
      • 8.4.6.5.4 Market size and forecast, by End User
      • 8.4.6.6 Rest Of Asia Pacific
      • 8.4.6.6.1 Market size and forecast, by Types
      • 8.4.6.6.2 Market size and forecast, by Method
      • 8.4.6.6.3 Market size and forecast, by Technology
      • 8.4.6.6.4 Market size and forecast, by End User
  • 8.5 LAMEA
    • 8.5.1 Key trends and opportunities
    • 8.5.2 LAMEA Market size and forecast, by Types
    • 8.5.3 LAMEA Market size and forecast, by Method
    • 8.5.4 LAMEA Market size and forecast, by Technology
    • 8.5.5 LAMEA Market size and forecast, by End User
    • 8.5.6 LAMEA Market size and forecast, by country
      • 8.5.6.1 Brazil
      • 8.5.6.1.1 Market size and forecast, by Types
      • 8.5.6.1.2 Market size and forecast, by Method
      • 8.5.6.1.3 Market size and forecast, by Technology
      • 8.5.6.1.4 Market size and forecast, by End User
      • 8.5.6.2 Saudi Arabia
      • 8.5.6.2.1 Market size and forecast, by Types
      • 8.5.6.2.2 Market size and forecast, by Method
      • 8.5.6.2.3 Market size and forecast, by Technology
      • 8.5.6.2.4 Market size and forecast, by End User
      • 8.5.6.3 South Africa
      • 8.5.6.3.1 Market size and forecast, by Types
      • 8.5.6.3.2 Market size and forecast, by Method
      • 8.5.6.3.3 Market size and forecast, by Technology
      • 8.5.6.3.4 Market size and forecast, by End User
      • 8.5.6.4 Rest of LAMEA
      • 8.5.6.4.1 Market size and forecast, by Types
      • 8.5.6.4.2 Market size and forecast, by Method
      • 8.5.6.4.3 Market size and forecast, by Technology
      • 8.5.6.4.4 Market size and forecast, by End User

CHAPTER 9: COMPANY LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Key developments

CHAPTER 10: COMPANY PROFILES

  • 10.1 Abott Laboratories
    • 10.1.1 Company overview
    • 10.1.2 Company snapshot
    • 10.1.3 Operating business segments
    • 10.1.4 Product portfolio
    • 10.1.5 Business performance
    • 10.1.6 Key strategic moves and developments
  • 10.2 F.hoffman La roche
    • 10.2.1 Company overview
    • 10.2.2 Company snapshot
    • 10.2.3 Operating business segments
    • 10.2.4 Product portfolio
    • 10.2.5 Business performance
    • 10.2.6 Key strategic moves and developments
  • 10.3 Thermofischer Inc
    • 10.3.1 Company overview
    • 10.3.2 Company snapshot
    • 10.3.3 Operating business segments
    • 10.3.4 Product portfolio
    • 10.3.5 Business performance
    • 10.3.6 Key strategic moves and developments
  • 10.4 Hologic Inc
    • 10.4.1 Company overview
    • 10.4.2 Company snapshot
    • 10.4.3 Operating business segments
    • 10.4.4 Product portfolio
    • 10.4.5 Business performance
    • 10.4.6 Key strategic moves and developments
  • 10.5 Biomerieux SA
    • 10.5.1 Company overview
    • 10.5.2 Company snapshot
    • 10.5.3 Operating business segments
    • 10.5.4 Product portfolio
    • 10.5.5 Business performance
    • 10.5.6 Key strategic moves and developments
  • 10.6 Quidel Corporation
    • 10.6.1 Company overview
    • 10.6.2 Company snapshot
    • 10.6.3 Operating business segments
    • 10.6.4 Product portfolio
    • 10.6.5 Business performance
    • 10.6.6 Key strategic moves and developments
  • 10.7 Bio Rad laborateries
    • 10.7.1 Company overview
    • 10.7.2 Company snapshot
    • 10.7.3 Operating business segments
    • 10.7.4 Product portfolio
    • 10.7.5 Business performance
    • 10.7.6 Key strategic moves and developments
  • 10.8 Beckton and Dickinson Company
    • 10.8.1 Company overview
    • 10.8.2 Company snapshot
    • 10.8.3 Operating business segments
    • 10.8.4 Product portfolio
    • 10.8.5 Business performance
    • 10.8.6 Key strategic moves and developments
  • 10.9 AdvanDx
    • 10.9.1 Company overview
    • 10.9.2 Company snapshot
    • 10.9.3 Operating business segments
    • 10.9.4 Product portfolio
    • 10.9.5 Business performance
    • 10.9.6 Key strategic moves and developments
  • 10.10 Beckman Coulter
    • 10.10.1 Company overview
    • 10.10.2 Company snapshot
    • 10.10.3 Operating business segments
    • 10.10.4 Product portfolio
    • 10.10.5 Business performance
    • 10.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 2. PNEUMONIA TESTING MARKET REVENUE, FOR CONSUMABLES, BY REGION , 2020-2030,($MILLION)
  • TABLE 3. PNEUMONIA TESTING MARKET FOR CONSUMABLES BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 4. PNEUMONIA TESTING MARKET REVENUE, FOR ANALYZERS, BY REGION , 2020-2030,($MILLION)
  • TABLE 5. PNEUMONIA TESTING MARKET FOR ANALYZERS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 6. GLOBAL PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 7. PNEUMONIA TESTING MARKET REVENUE, FOR IMMUNODIAGNOSTICS, BY REGION , 2020-2030,($MILLION)
  • TABLE 8. PNEUMONIA TESTING MARKET FOR IMMUNODIAGNOSTICS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 9. PNEUMONIA TESTING MARKET REVENUE, FOR MOLECULAR DIAGNOSTICS, BY REGION , 2020-2030,($MILLION)
  • TABLE 10. PNEUMONIA TESTING MARKET FOR MOLECULAR DIAGNOSTICS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 11. PNEUMONIA TESTING MARKET REVENUE, FOR POINT OF CARE TESTING, BY REGION , 2020-2030,($MILLION)
  • TABLE 12. PNEUMONIA TESTING MARKET FOR POINT OF CARE TESTING BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 13. GLOBAL PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 14. PNEUMONIA TESTING MARKET REVENUE, FOR ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION , 2020-2030,($MILLION)
  • TABLE 15. PNEUMONIA TESTING MARKET FOR ENZYME LINKED IMMUNOSORBENT ASSAY BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 16. PNEUMONIA TESTING MARKET REVENUE, FOR IMMUNOFLUORESCENCE, BY REGION , 2020-2030,($MILLION)
  • TABLE 17. PNEUMONIA TESTING MARKET FOR IMMUNOFLUORESCENCE BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 18. PNEUMONIA TESTING MARKET REVENUE, FOR WESTERN BLOT, BY REGION , 2020-2030,($MILLION)
  • TABLE 19. PNEUMONIA TESTING MARKET FOR WESTERN BLOT BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 20. PNEUMONIA TESTING MARKET REVENUE, FOR POLYMERASE CHAIN REACTION, BY REGION , 2020-2030,($MILLION)
  • TABLE 21. PNEUMONIA TESTING MARKET FOR POLYMERASE CHAIN REACTION BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 22. PNEUMONIA TESTING MARKET REVENUE, FOR IMMUNOHISTOCHEMISTRY, BY REGION , 2020-2030,($MILLION)
  • TABLE 23. PNEUMONIA TESTING MARKET FOR IMMUNOHISTOCHEMISTRY BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 24. PNEUMONIA TESTING MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
  • TABLE 25. PNEUMONIA TESTING MARKET FOR OTHERS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 26. GLOBAL PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 27. PNEUMONIA TESTING MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION)
  • TABLE 28. PNEUMONIA TESTING MARKET FOR HOSPITALS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 29. PNEUMONIA TESTING MARKET REVENUE, FOR DIAGNOSTIC LABORATORIES, BY REGION , 2020-2030,($MILLION)
  • TABLE 30. PNEUMONIA TESTING MARKET FOR DIAGNOSTIC LABORATORIES BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 31. PNEUMONIA TESTING MARKET REVENUE, FOR HOMECARE, BY REGION , 2020-2030,($MILLION)
  • TABLE 32. PNEUMONIA TESTING MARKET FOR HOMECARE BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 33. PNEUMONIA TESTING MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
  • TABLE 34. PNEUMONIA TESTING MARKET FOR OTHERS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 35. PNEUMONIA TESTING MARKET, BY REGION, 2020-2030,($MILLION)
  • TABLE 36. NORTH AMERICA PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 37. NORTH AMERICA PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 38. NORTH AMERICA PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 39. NORTH AMERICA PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 40. NORTH AMERICA PNEUMONIA TESTING MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 41. U.S. PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 42. U.S. PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 43. U.S. PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 44. U.S. PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 45. CANADA PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 46. CANADA PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 47. CANADA PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 48. CANADA PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 49. MEXICO PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 50. MEXICO PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 51. MEXICO PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 52. MEXICO PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 53. EUROPE PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 54. EUROPE PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 55. EUROPE PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 56. EUROPE PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 57. EUROPE PNEUMONIA TESTING MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 58. GERMANY PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 59. GERMANY PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 60. GERMANY PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 61. GERMANY PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 62. FRANCE PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 63. FRANCE PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 64. FRANCE PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 65. FRANCE PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 66. U.K. PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 67. U.K. PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 68. U.K. PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 69. U.K. PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 70. ITALY PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 71. ITALY PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 72. ITALY PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 73. ITALY PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 74. SPAIN PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 75. SPAIN PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 76. SPAIN PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 77. SPAIN PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 78. REST OF EUROPE PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 79. REST OF EUROPE PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 80. REST OF EUROPE PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 81. REST OF EUROPE PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 82. ASIA-PACIFIC PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 83. ASIA-PACIFIC PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 84. ASIA-PACIFIC PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 85. ASIA-PACIFIC PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 86. ASIA-PACIFIC PNEUMONIA TESTING MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 87. JAPAN PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 88. JAPAN PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 89. JAPAN PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 90. JAPAN PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 91. CHINA PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 92. CHINA PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 93. CHINA PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 94. CHINA PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 95. AUSTRALIA PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 96. AUSTRALIA PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 97. AUSTRALIA PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 98. AUSTRALIA PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 99. INDIA PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 100. INDIA PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 101. INDIA PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 102. INDIA PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 103. SOUTH KOREA PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 104. SOUTH KOREA PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 105. SOUTH KOREA PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 106. SOUTH KOREA PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 107. REST OF ASIA PACIFIC PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 108. REST OF ASIA PACIFIC PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 109. REST OF ASIA PACIFIC PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 110. REST OF ASIA PACIFIC PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 111. LAMEA PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 112. LAMEA PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 113. LAMEA PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 114. LAMEA PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 115. LAMEA PNEUMONIA TESTING MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 116. BRAZIL PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 117. BRAZIL PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 118. BRAZIL PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 119. BRAZIL PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 120. SAUDI ARABIA PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 121. SAUDI ARABIA PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 122. SAUDI ARABIA PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 123. SAUDI ARABIA PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 124. SOUTH AFRICA PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 125. SOUTH AFRICA PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 126. SOUTH AFRICA PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 127. SOUTH AFRICA PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 128. REST OF LAMEA PNEUMONIA TESTING MARKET, BY TYPES, 2020-2030,($MILLION)
  • TABLE 129. REST OF LAMEA PNEUMONIA TESTING MARKET, BY METHOD, 2020-2030,($MILLION)
  • TABLE 130. REST OF LAMEA PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
  • TABLE 131. REST OF LAMEA PNEUMONIA TESTING MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 132.ABOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 133.ABOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 134.ABOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 135.ABOTT LABORATORIES: NET SALES,
  • TABLE 136.ABOTT LABORATORIES: KEY STRATERGIES
  • TABLE 137.F.HOFFMAN LA ROCHE: COMPANY SNAPSHOT
  • TABLE 138.F.HOFFMAN LA ROCHE: OPERATING SEGMENTS
  • TABLE 139.F.HOFFMAN LA ROCHE: PRODUCT PORTFOLIO
  • TABLE 140.F.HOFFMAN LA ROCHE: NET SALES,
  • TABLE 141.F.HOFFMAN LA ROCHE: KEY STRATERGIES
  • TABLE 142.THERMOFISCHER INC: COMPANY SNAPSHOT
  • TABLE 143.THERMOFISCHER INC: OPERATING SEGMENTS
  • TABLE 144.THERMOFISCHER INC: PRODUCT PORTFOLIO
  • TABLE 145.THERMOFISCHER INC: NET SALES,
  • TABLE 146.THERMOFISCHER INC: KEY STRATERGIES
  • TABLE 147.HOLOGIC INC: COMPANY SNAPSHOT
  • TABLE 148.HOLOGIC INC: OPERATING SEGMENTS
  • TABLE 149.HOLOGIC INC: PRODUCT PORTFOLIO
  • TABLE 150.HOLOGIC INC: NET SALES,
  • TABLE 151.HOLOGIC INC: KEY STRATERGIES
  • TABLE 152.BIOMERIEUX SA: COMPANY SNAPSHOT
  • TABLE 153.BIOMERIEUX SA: OPERATING SEGMENTS
  • TABLE 154.BIOMERIEUX SA: PRODUCT PORTFOLIO
  • TABLE 155.BIOMERIEUX SA: NET SALES,
  • TABLE 156.BIOMERIEUX SA: KEY STRATERGIES
  • TABLE 157.QUIDEL CORPORATION: COMPANY SNAPSHOT
  • TABLE 158.QUIDEL CORPORATION: OPERATING SEGMENTS
  • TABLE 159.QUIDEL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 160.QUIDEL CORPORATION: NET SALES,
  • TABLE 161.QUIDEL CORPORATION: KEY STRATERGIES
  • TABLE 162.BIO RAD LABORATERIES: COMPANY SNAPSHOT
  • TABLE 163.BIO RAD LABORATERIES: OPERATING SEGMENTS
  • TABLE 164.BIO RAD LABORATERIES: PRODUCT PORTFOLIO
  • TABLE 165.BIO RAD LABORATERIES: NET SALES,
  • TABLE 166.BIO RAD LABORATERIES: KEY STRATERGIES
  • TABLE 167.BECKTON AND DICKINSON COMPANY: COMPANY SNAPSHOT
  • TABLE 168.BECKTON AND DICKINSON COMPANY: OPERATING SEGMENTS
  • TABLE 169.BECKTON AND DICKINSON COMPANY: PRODUCT PORTFOLIO
  • TABLE 170.BECKTON AND DICKINSON COMPANY: NET SALES,
  • TABLE 171.BECKTON AND DICKINSON COMPANY: KEY STRATERGIES
  • TABLE 172.ADVANDX: COMPANY SNAPSHOT
  • TABLE 173.ADVANDX: OPERATING SEGMENTS
  • TABLE 174.ADVANDX: PRODUCT PORTFOLIO
  • TABLE 175.ADVANDX: NET SALES,
  • TABLE 176.ADVANDX: KEY STRATERGIES
  • TABLE 177.BECKMAN COULTER: COMPANY SNAPSHOT
  • TABLE 178.BECKMAN COULTER: OPERATING SEGMENTS
  • TABLE 179.BECKMAN COULTER: PRODUCT PORTFOLIO
  • TABLE 180.BECKMAN COULTER: NET SALES,
  • TABLE 181.BECKMAN COULTER: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.PNEUMONIA TESTING MARKET SEGMENTATION
  • FIGURE 2.PNEUMONIA TESTING MARKET,2020-2030
  • FIGURE 3.PNEUMONIA TESTING MARKET,2020-2030
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.PNEUMONIA TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.PNEUMONIA TESTING MARKET,BY TYPES,2020(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ANALYZERS PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 15.PNEUMONIA TESTING MARKET,BY METHOD,2020(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF IMMUNODIAGNOSTICS PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MOLECULAR DIAGNOSTICS PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF POINT OF CARE TESTING PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 19.PNEUMONIA TESTING MARKET,BY TECHNOLOGY,2020(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF ENZYME LINKED IMMUNOSORBENT ASSAY PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF IMMUNOFLUORESCENCE PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF WESTERN BLOT PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF POLYMERASE CHAIN REACTION PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF IMMUNOHISTOCHEMISTRY PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 26.PNEUMONIA TESTING MARKET,BY END USER,2020(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF HOSPITALS PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC LABORATORIES PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 29.COMPARATIVE SHARE ANALYSIS OF HOMECARE PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 30.COMPARATIVE SHARE ANALYSIS OF OTHERS PNEUMONIA TESTING MARKET,2020-2030(%)
  • FIGURE 31.PNEUMONIA TESTING MARKET BY REGION,2020
  • FIGURE 32.U.S. PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 33.CANADA PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 34.MEXICO PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 35.GERMANY PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 36.FRANCE PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 37.U.K. PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 38.ITALY PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 39.SPAIN PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 40.REST OF EUROPE PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 41.JAPAN PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 42.CHINA PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 43.AUSTRALIA PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 44.INDIA PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 45.SOUTH KOREA PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 46.REST OF ASIA PACIFIC PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 47.BRAZIL PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 48.SAUDI ARABIA PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 49.SOUTH AFRICA PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 50.REST OF LAMEA PNEUMONIA TESTING MARKET,2020-2030($MILLION)
  • FIGURE 51. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 52. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 53. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 54.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 55.COMPETITIVE DASHBOARD
  • FIGURE 56.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 57.ABOTT LABORATORIES.: NET SALES ,($MILLION)
  • FIGURE 58.F.HOFFMAN LA ROCHE.: NET SALES ,($MILLION)
  • FIGURE 59.THERMOFISCHER INC.: NET SALES ,($MILLION)
  • FIGURE 60.HOLOGIC INC.: NET SALES ,($MILLION)
  • FIGURE 61.BIOMERIEUX SA.: NET SALES ,($MILLION)
  • FIGURE 62.QUIDEL CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 63.BIO RAD LABORATERIES.: NET SALES ,($MILLION)
  • FIGURE 64.BECKTON AND DICKINSON COMPANY.: NET SALES ,($MILLION)
  • FIGURE 65.ADVANDX.: NET SALES ,($MILLION)
  • FIGURE 66.BECKMAN COULTER.: NET SALES ,($MILLION)